Qlucore AB (publ) - Asset Resilience Ratio

Latest as of December 2011: 0.17%

Qlucore AB (publ) (NOVKAN) has an Asset Resilience Ratio of 0.17% as of December 2011. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read NOVKAN current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Skr67.00K

≈ $7.21K USD Cash + Short-term Investments

Total Assets

Skr39.74 Million

≈ $4.28 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2011)

This chart shows how Qlucore AB (publ)'s Asset Resilience Ratio has changed over time. See what is Qlucore AB (publ)'s book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Qlucore AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Qlucore AB (publ) (NOVKAN) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr67.00K	0.17%
Total Liquid Assets	Skr67.00K	0.17%

Asset Resilience Insights

Limited Liquidity: Qlucore AB (publ) maintains only 0.17% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Qlucore AB (publ) Industry Peers by Asset Resilience Ratio

Compare Qlucore AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Allakos Inc NASDAQ:ALLK	Biotechnology	52.08%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	43.36%
Arcutis Biotherapeutics Inc NASDAQ:ARQT	Biotechnology	41.14%
Youcare Pharmaceutical Group Co. Ltd. A SHG:688658	Biotechnology	10.25%
MoonLake Immunotherapeutics NASDAQ:MLTX	Biotechnology	14.01%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%

Annual Asset Resilience Ratio for Qlucore AB (publ) (2010–2011)

The table below shows the annual Asset Resilience Ratio data for Qlucore AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2011-12-31	0.17%	Skr67.00K ≈ $7.21K	Skr39.74 Million ≈ $4.28 Million	-3.40pp
2010-12-31	3.57%	Skr500.00K ≈ $53.81K	Skr14.01 Million ≈ $1.51 Million	--

pp = percentage points

About Qlucore AB (publ)

ST:NOVKAN USA Biotechnology

Market Cap

$326.04K

Skr3.03 Million SEK

Market Cap Rank

#30885 Global

#6075 in USA

Share Price

Skr0.03

Change (1 day)

-43.95%

52-Week Range

Skr0.03 - Skr0.23

All Time High

Skr0.23